AI3 Bio, Inc. funding
AI3 Bio, Inc., a biotechnology company based in Watertown, MA, filed a Form D with the SEC on November 4, 2026 and reported $48.3M raised. It filed 2 new offerings in this period, totaling $48.3M.
Amount raised$48.3M
Offering size$48.3M
Filed with the SECNovember 4, 2026
First saleJune 9, 2026
IndustryBiotechnology
SecuritiesEquity
LocationWatertown, MA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far8
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Nov 4
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| November 4, 2026 | $48.3M | $48.3M | Equity |
| November 4, 2026 | $0 | Open-ended | Equity |
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$16.3M · Oct 23Other Health CareCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health CareBridgeHealth Pharmaceuticals, Inc.$3.5M · Nov 5PharmaceuticalsQuiver Holdings Inc.$3M · Oct 21BiotechnologyNocturnal Inc.$1.9M · Oct 20Other Health Care